“…36 This self-assembled synthetic strategy enables control over the sizes, surface chemistry, and payloads of SNP vectors for a wide range of diagnostic and therapeutic applications, such as positron emission tomography (PET) imaging, 37 magnetic resonance imaging (MRI), 43 photothermal treatment, 39 on-demand release of a drugs, 43 as well as highly efficient delivery of genes, 40,48,49 transcription factors, 50 and drug-polymer conjugates. 42 As for DNA-encapsulated SNPs (DNA⊂SNPs), Figure 1b illustrates the mechanism of the supramolecular synthetic strategy, 37–43 CD-PEI and Ad-PAMAM first self-assemble, via the cooperation of Ad/CD recognition motifs, into cationic hydrogel networks that can encapsulate DNA plasmids, thus creating the cores of SNPs. 39,40 The ligand module (Ad-PEG) then acts as a capping/solvation reagent that constrains continuous growth of the DNA-encapsulated hydrogel networks and simultaneously confers desired solubility, structural stability, and stealth (in circulatory system) to the resulting DNA⊂SNPs with controllable sizes of ca.…”